MEMENTO - A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure with Cardiac Magnetic Resonance Imaging [CMR] (NCT06112743)
MEMENTO
This trial is No longer recruiting
Registration number NCT06112743
Program & service
This trial is being run with the Heart & Lung service, and as part of the Cardiology program.
Trial phase
Phase 4
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Sarah Gutman
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR